Assembly Biosciences ASMB EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's EPS (diluted)?
- Assembly Biosciences (ASMB) reported EPS (diluted) of -$0.54 in Q1 2026.
- How has Assembly Biosciences's EPS (diluted) changed year-over-year?
- Assembly Biosciences's EPS (diluted) increased by 53.8% year-over-year, from -$1.17 to -$0.54.
- What is the long-term trend for Assembly Biosciences's EPS (diluted)?
- Over 3 years (2021 to 2024), Assembly Biosciences's EPS (diluted) has grown at a 30.6% compound annual growth rate (CAGR), from -$3.02 to -$6.72.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.